Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COVID-19 Induced Telogen Effluvium

NCT04834102 is registered in ClinicalTrials.gov with Istanbul Medeniyet University as lead sponsor.

NCT NCT04834102
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04834102 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COVID-19 Induced Telogen Effluvium
Lead sponsor
Istanbul Medeniyet University
Phase
Observational
Overall status
Unknown status
Start date
January 27, 2021
Completion date
April 27, 2021
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alopecia, covid19, sars-cov infection, telogen effluvium